Patalganga Plant Gets Major Expansion
Key Highlights
- Novonesis plans to invest Rs 6,600 crore in Maharashtra.
- The investment will expand its enzyme manufacturing facility at Patalganga.
- The expanded facility is expected to be operational by 2030.
- Products will serve biofuels, food, beverages and household-care industries.
- Emerging markets such as India, Africa and the Middle East are key targets.
- The facility will incorporate water recycling and heat-pump technology.
- The plant was originally commissioned in 2019.
Updated News Article
Danish biosolutions company Novonesis has announced a Rs 6,600 crore investment to expand its enzyme manufacturing facility at Patalganga in Maharashtra, strengthening its production capabilities to serve growing demand across emerging markets.
The expansion is expected to take place over the next four years, with the upgraded facility projected to become fully operational by 2030.
The expanded plant will manufacture enzymes used across several industries, including biofuels, household care, food and beverages. Novonesis said the project will help the company meet increasing demand from emerging markets, particularly India, South Asia, the Middle East and Africa.
Novonesis President and Chief Executive Ester Baiget said these markets represent an increasingly important and growing part of the company’s business and are expected to expand faster than developed markets in the coming years.
The company’s Chief Operating Officer Anders Lund said the Patalganga facility would bring production closer to customers while improving scale, operational resilience, efficiency and supply flexibility.
The investment also reflects the growing importance of biotechnology-based industrial solutions. Enzymes have applications across a wide range of industries, including food processing, detergents, biofuel production and industrial manufacturing.
Novonesis plans to incorporate resource-efficient technologies into the expanded facility. Freshwater recycling will reduce the amount of water drawn by the plant, while integrated heat pumps will help lower energy consumption.
The company’s regional President for the Middle East, India and Africa, Krishna Mohan Puvvada, highlighted India’s BioE3 policy, describing it as an important step toward unlocking the economic, social and environmental potential of biosolutions.
The Patalganga facility has an established manufacturing history. It was originally commissioned in 2019 by Novozymes. Novozymes later merged with Chr. Hansen, resulting in the creation of Novonesis in 2024.
Patalganga is located near Mumbai and has developed into a major industrial cluster. The area houses several chemical, pharmaceutical and petrochemical operations, making it an important manufacturing location in Maharashtra.
The new investment could strengthen the state’s industrial ecosystem while creating additional opportunities for engineering, logistics, technology and industrial-service providers.
Novonesis has previously invested in manufacturing expansions in markets including Thailand, the United States and Brazil as part of its broader capital expenditure programme.
The company’s latest commitment to Maharashtra comes as global manufacturers increasingly look to establish resilient supply chains closer to high-growth markets. India’s expanding industrial base and large consumer market make the country an increasingly attractive location for manufacturing and technology investments.
For Novonesis, the Patalganga expansion is expected to provide additional production capacity while improving access to customers across India and neighbouring markets.
The emphasis on lower water and energy consumption also reflects the increasing importance of sustainability in industrial investment. As manufacturers face growing pressure to improve resource efficiency, technologies such as water recycling and heat recovery are becoming increasingly relevant.
The expanded plant is expected to become a significant part of Novonesis’ regional manufacturing network once it reaches full operational capacity.
Novonesis investment India, Rs 6600 crore investment, Patalganga enzyme plant, Novonesis Maharashtra, biotechnology India, enzyme manufacturing India, BioE3 policy, industrial investment Maharashtra, sustainable manufacturing India, Novonesis plant expansion
